Posology: 1 dragée 2-3 times a day, as advised by the physician. During treatment: as prescribed by the physician.
Patients with hepatic or renal impairment: No data are available (see Pharmacology: Pharmacokinetics under Actions).
The elderly: No data are available.
Paediatric population: The safety and efficacy of otilonium bromide in patients below 18 years have not been established, therefore this medicinal product is not recommended for use in this population.
Method of administration: Oral use.
The dragée must be swallowed whole, with a glass of water, preferably before meals.
Sign Out